SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,157,265 | -40.4% | 148,572 | -14.1% | 0.00% | -50.0% |
| Q2 2023 | $3,621,288 | +23.3% | 173,019 | +24.4% | 0.00% | +33.3% |
| Q1 2023 | $2,937,095 | -28.1% | 139,067 | -13.3% | 0.00% | -40.0% |
| Q4 2022 | $4,083,071 | +32.7% | 160,435 | +25.3% | 0.01% | +25.0% |
| Q3 2022 | $3,077,000 | +14.0% | 128,028 | +3.8% | 0.00% | +100.0% |
| Q4 2021 | $2,699,000 | -58.1% | 123,303 | -63.4% | 0.00% | -66.7% |
| Q3 2021 | $6,443,000 | -8.6% | 337,146 | -17.9% | 0.01% | 0.0% |
| Q2 2021 | $7,048,000 | -45.1% | 410,467 | -28.5% | 0.01% | -50.0% |
| Q1 2021 | $12,833,000 | -11.9% | 573,938 | -12.4% | 0.01% | -7.7% |
| Q4 2020 | $14,568,000 | +295.7% | 655,007 | +162.6% | 0.01% | +225.0% |
| Q3 2020 | $3,682,000 | +146.9% | 249,427 | +148.0% | 0.00% | +100.0% |
| Q2 2020 | $1,491,000 | +75.2% | 100,591 | +29.7% | 0.00% | +100.0% |
| Q1 2020 | $851,000 | +52.2% | 77,573 | +21.7% | 0.00% | 0.0% |
| Q4 2019 | $559,000 | +176.7% | 63,733 | +176.3% | 0.00% | – |
| Q4 2017 | $202,000 | +10.4% | 23,063 | +47.6% | 0.00% | – |
| Q3 2017 | $183,000 | – | 15,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |